Kristin Wood
Family Medicine · Indianapolis, INNPI 1326117607
Payments from drug & device makers
Across 153 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$755
- Boehringer Ingelheim$322
- Novo Nordisk$294
- GSK$196
- Lilly USA, LLC$193
- Amgen$192
- plus $711 from 22 others
What the payments were for
- Food & beverage$2,664100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $755 |
| Boehringer Ingelheim | 18 | $322 |
| Novo Nordisk | 18 | $294 |
| GSK | 12 | $196 |
| Lilly USA, LLC | 20 | $193 |
| Amgen | 10 | $192 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $107 |
| Biohaven Pharmaceuticals, Inc. | 3 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Ultragenyx Pharmaceutical Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Exact Sciences | 2 | $29 |
| Merck | 2 | $28 |
| AstraZeneca | 2 | $28 |
| Novartis | 1 | $25 |
| Gilead | 2 | $24 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Nalpropion Pharmaceuticals LLC | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| Aquestive Therapeutics, Inc. | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Bayer | 1 | $13 |
| Pfizer | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
How this compares
$2,664 in reported general payments places this provider in the 75th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ezetimibe | 12 | $241 |
| Atorvastatin Calcium | 29 | $106 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $96 |
| Omeprazole | 27 | $94 |
| Gabapentin | 15 | $88 |
| Escitalopram Oxalate | 11 | $83 |
| Levothyroxine Sodium | 20 | $77 |
| Metformin Hcl ErMetformin Hcl | 16 | $77 |
| Alendronate Sodium | 17 | $29 |
| Rosuvastatin Calcium | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Indianapolis
- Blair BrengleIndianapolis$10.6M
- Steven SmithIndianapolis$2.5M
- Richard TannerIndianapolis$1.6M
- Richard FeldmanIndianapolis$476K
- Joe BanksIndianapolis$294K
- Jakoda SniderIndianapolis$107K
- Robert ClutterIndianapolis$77K
- Gaylen KeltonIndianapolis$42K
- Daniela LoboIndianapolis$38K
- Haihong MaoIndianapolis$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.